Pharmafile Logo
Pharmafocus logo
Advanced Search

Efexor successor approved in US

March 7, 2008
Sales and Marketing

Wyeth's Pristiq, a refined version of its top-selling depression treatment Efexor, has been approved in the US. Pristiq (desvenlafaxine) delivers …

News

Renovo wounded by cosmetic drug setback

March 7, 2008
Research and Development, Sales and Marketing

UK biotech company Renovo has received disappointing clinical trial results for its new anti-scarring and wound healing drug Juvista. The …

News

Frontline doctor to lead UK diabetes strategy

March 7, 2008

Dr Rowan Hillson has been appointed the new national clinical director for diabetes. Dr Hillson is a consultant physician and …

News

NICE’s approach to benefits and costs to be reviewed

March 7, 2008
Sales and Marketing

The pharmaceutical industry has welcomed plans to review how NICE assesses the benefits and costs of drugs, with the hope …

News

Diabetes nurses would cut emergency admissions

March 7, 2008
Sales and Marketing

Specialist nurses could help to cut the number of diabetes patients being admitted to hospital as emergency cases, a new …

News

Latest news from Datamonitor

March 5, 2008
Sales and Marketing

APP Pharma granted approval for generic anticancer drug APP Pharmaceuticals has received final approval from the FDA of its abbreviated …

News

GSK abandons malaria drugs

March 4, 2008
Sales and Marketing reg, safety

News

Government remains tight-lipped on PPRS

February 29, 2008
Sales and Marketing par

The Department of Health has refused to comment on renewed speculation on the future of the UK's medicines pricing system …

News

FDA rejects long-acting version of Zyprexa

February 29, 2008
Sales and Marketing

Lilly has suffered a setback after the US medicines regulator rejected a new version of its top-selling product Zyprexa. The …

News

Working with NICE: the ingredients for success

February 29, 2008
Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma

NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …

Feature

Avastin receives surprise FDA approval

February 29, 2008
Sales and Marketing

The FDA gone against the advice of its own advisory panel to approve Genentech's Avastin as a first-line treatment for …

News

AstraZeneca fined $200m over Medicaid pricing

February 29, 2008
Sales and Marketing

A US court has ruled AstraZeneca must pay more than $200 million for inflating the prices of drugs prescribed under …

News

New pharma-NHS collaboration in preparation

February 28, 2008

News

Latest news from Datamonitor

February 28, 2008
Sales and Marketing

Algeta to initiate US clinical trials for prostate cancer drug Cancer therapeutics company Algeta has said that it will commence …

News

Dr Paul Hooper

February 28, 2008
Sales and Marketing

News

GlaxoSmithKline’s Tyverb poised for launch in the UK

February 27, 2008
Research and Development

GlaxoSmithKline says its new breast cancer drug Tyverb is ready for launch and could be prescribed to the first UK …

News

Health comms agency Hive launched

February 27, 2008
Medical Communications

A group of experienced healthcare communications executives have launched Hive which they claim represents a 'next generation' of agency to …

News

Boehringer Ingelheim’s anti-clotting pill ready for launch

February 15, 2008
Research and Development

Boehringer Ingelheim's Pradaxa is expected to gain final regulatory approval shortly and could make a major impact in the anti-thrombosis …

News

Latest news from Datamonitor

February 15, 2008
Research and Development

Introgen and Moffitt initiate Phase II lung cancer trial Introgen Therapeutics and Moffitt Cancer Center have reported that a randomized, …

News

Britain a ‘Prozac Nation’, say Lib Dems

February 8, 2008

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026